Dichloromethane → HCID 20506149、化合物

HRID 354760ノート

反応式

HRID 354760 の反応式
[NH2:1][C:2]1[CH:3]=[CH:4][C:5]2[N:11]([CH3:12])[C:10](=[O:13])[C:9]([CH3:15])([CH3:14])[N:8]=[C:7]([C:16]3[CH:21]=[CH:20][CH:19]=[CH:18][C:17]=3[F:22])[C:6]=2[CH:23]=1.Cl.[NH2:25][C:26]([CH3:31])([CH3:30])[C:27](Cl)=[O:28].C(=O)([O-])[O-].[K+].[K+].C(Cl)Cl>O1CCCC1.O>[NH2:25][C:26]([CH3:31])([CH3:30])[C:27]([NH:1][C:2]1[CH:3]=[CH:4][C:5]2[N:11]([CH3:12])[C:10](=[O:13])[C:9]([CH3:15])([CH3:14])[N:8]=[C:7]([C:16]3[CH:21]=[CH:20][CH:19]=[CH:18][C:17]=3[F:22])[C:6]=2[CH:23]=1)=[O:28]

参加物

7

実験手順

8 g (0.026 mol) of 7-amino-5-(o-fluorophenyl)-1,3-dihydro-1,3,3-trimethyl-2H-1,4-benzodiazepin-2-one are stirred at room temperature for 1 hour with 5 g of α-aminoisobutyric acid chloride hydrochloride in 30 ml of tetrahydrofuran, 8 g of potassium carbonate are subsequently added thereto and, after a further 15 minutes, the mixture is treated with methylene chloride and water. The organic phase is separated and the aqueous phase is extracted four times with methylene chloride. The combined organic extracts are dried and evaporated. The residue is purified on 350 g of silica gel with methylene chloride/ethyl acetate (1:1) and ethyl acetate as the elution agent. From ethyl acetate/ether there is obtained 2-amino-N-[5-(o-fluorophenyl)-2,3-dihydro-1,3,3-trimethyl-2-oxo-1H-1,4-benzodiazepin-7-yl]-2-methylpropionamide of melting point 250°.

後処理

  1. additionare subsequently added
  2. customThe organic phase is separated
  3. extractionthe aqueous phase is extracted four times with methylene chloride
  4. customThe combined organic extracts are dried
  5. customevaporated
  6. customThe residue is purified on 350 g of silica gel with methylene chloride/ethyl acetate (1:1) and ethyl acetate as the elution agent

出典と根拠

ORDレコード
ord-11951ee022d94d62a7ce787340d00e77
出典データセット
uspto-grants-1983_03
特許番号
US04377522

反応ノート

読み込み中…